Unlocking the potential of disease prevention through regulatory science
D
Daniel J. O’Connor
A
Alison C. Cave
A
Alejandro F. Frangi
J
John Hardy
J
James Kennard
K
Kathryn Goodey
V
Virginia Acha
D
Deb Lancaster
P
Paul Fisher
N
Natalie Schmidt
S
Sheuli Porkess
A
Alice Fabre
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 25, Issue 5
Published
May 01, 2026
Pages
333-334
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (12)
D
Daniel J. O’Connor
A
Alison C. Cave
A
Alejandro F. Frangi
J
John Hardy
J
James Kennard
K
Kathryn Goodey
V
Virginia Acha
D
Deb Lancaster
P
Paul Fisher
N
Natalie Schmidt
S
Sheuli Porkess
A
Alice Fabre
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w